focus mul - UKSH Universitätsklinikum Schleswig-Holstein

51. Raasch W, Jungbluth B, Schäfer U, Hauser W, Dominiak P (2003) Norepinephrine
release is reduced by I(1)-receptors in addition to alpha(2)adrenoceptors.
Ann N Y Acad Sci 1009:270-273
52. Radke PW, Voswinkel M, Reith M, Kaiser A, Haager PK, Hanrath P,
Hoffmann R (2004) Relation of fasting insulin plasma levels to restenosis
after elective coronary stent implantation in patients without diabetes
mellitus. Am J Cardiol 93:639-641
53. Radke PW, Kobella S, Kaiser A, Franke A, Schubert D, Grube E, Hanrath P,
Hoffmann R (2004) Treatment of In-Stent Restenosis Using A Paclitaxel
Eluting Stent: Acute Results and Long-Term Follow-Up of a Matched
Comparison With Intracoronary â-Radiation Therapy. Eur Heart J 25:920-
925
54. Radke PW, Heinl-Green A, Frass OM, Griesenbach U, Ferrari S, Geddes DM,
Alton EWFW (2004) Effects of direct intramyocardial delivery of a plasmid
vector coding for VEGF165 on regional myocardial blood flow in a porcine
model of chronic myocardial ischaemia: evidence for a spatial "deliveryefficacy"
mismatch. Gene Therapy 11:1249-1255
55. Schäfer U, Burgdorf C, Engelhardt A, Raasch W, Kurz T, Richardt G (2003)
Moxonidine displays a presynaptic alpha-2-adrenoceptor-dependent
synergistic sympathoinhibitory action at imidazoline-1 receptors. Ann NY
Acad Sci 1009:265-269
56. Schunkert H, Erdmann J (2003) Well kept secrets of the genome. Eur Heart
J 24:501-503
57. Schunkert H (2003) Focal coronary atherosclerosis proximal to myocardial
bridging. Circulation 107:1944
58. Schunkert H (2003) Die Life-Studie. Internist 44:367-370
59. Wiegand UK, Bode F, Bonnemeier H, Eberhard F, Schlei M, Peters W (2003)
Long-term complication rates in ventricular, single lead VDD, and dual
chamber pacing. Pacing Clin Electrophysiol 26:1961-1969
60. Wiegand UK, Lejeune D, Boguschewski F, Bonnemeier H, Eberhardt F,
Schunkert H, Bode F (2004) Pocket hematoma after pacemaker or implantable
cardioverter defibrillator surgery: influence of patient morbidity,
operation strategy, and perioperative antiplatelet/anticoagulation therapy.
Chest 126:1177-1186
61. Wolfrum S, Grimm M, Heidbreder M, Dendorfer A, Katus HA, Liao JK,
Richardt G (2003) Acute reduction of myocardial infarct size by a hydroxymethyl
glutaryl coenzyme A reductase inhibitor is mediated by endothelial
nitric oxide synthase. J Cardiovasc Pharmacol 41:474-480
62. Wolfrum S, Jensen KS, Liao JK (2003) Endothelium-dependent effects of
statins. Arterioscler Thromb Vasc Biol 23:729-736
63. Wolfrum S, Dendorfer A, Schutt M, Weidtmann B, Heep A, Tempel K, Klein
HH, Dominiak P, Richardt G (2004) Simvastatin acutely reduces myocardial
reperfusion injury in vivo by activating the phosphatidylinositide 3-kinase/Akt
pathway. J Cardiovasc Pharmacol 44:348-355
64. Wolfrum S, Dendorfer A, Rikitake Y, Stalker TJ, Gong Y, Scalia R, Dominiak
P, Liao JK (2004) Inhibition of Rho-kinase leads to rapid activation of
334